Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Contact Gold Goes Back to the Bowl Zone to Hit Higher-Grade Gold

Going back to the Bowl Zone yields the desired results After a successful exploration campaign in 2018, wherein Contact Gold Corp. (C:TSX.V) confirmed the widespread presence of gold mineralization on its greater Pony Creek area (with very thick intervals such as 93...
Streetwise Reports | July 22, 2019 |

Will Straightup Resources Inc. become the next Great Bear Resources?

Straightup Resources Inc. (CSE: ST) is a new public company focused on advancing its flagship RLX and Belanger properties located in the Red Lake District of Ontario, Canada. Red Lake is one of the more prolific gold mining districts in the world with ~29 million oz gold hav...
James O'Rourke | June 30, 2020 |

Will Fed’s New Balance Sheet Policy be a Reason to Buy Gold?

As always, most analysts focus not on what they really should. After March FOMC meeting, everyone was talking about the more dovish dot-plot . But the Fed also announced that it will end the unwinding of its balance sheet in September. As these changes are revolutionary...
Arkadiusz Sieron | April 29, 2019 |

Buzz on the Bullboards: Top Stocks Plan Moves for 2022

( Ore stockpiles at the Kakula North decline containing 2.04 million tonnes grading 5.13% copper as of December 31, 2021. Image via Ivanhoe Mines Ltd.) 2022 started off with a bang for investors as many sectors were rocked by the spread of the Omicron Coronavir...
Stockhouse Editorial | January 18, 2022 |

Covid, debt and precious metals

Precious metals are loving the uncertainty the coronavirus has created. Despite limited successes some countries have had with reopening, the virus is nowhere near contained. As of this writing, close to 6 million worldwide are infected and 365,328 have died. The importan...
Richard (Rick) Mills | June 1, 2020 |

Buzz on the Bullboards: Hot Sector Favorites

One of the highlights of the Stockhouse Bullboards is that all companies are fair game. In our review of the weekly top 6 most viewed companies by sector, newcomers might expect big household names to dominate the charts. Instead, they find that Stockhouse investors are clued ...
Omri Wallach | September 11, 2019 |

Assertio Therapeutics' Shares Jump 50% on Sale of Shingles Pain Drug to Alvogen

Assertio Therapeutics' shares rose 50% today after the firm reported that it has agreed to sell all rights to its Gralise drug used in the treatment of pain from shingles to Alvogen for $127.5 million. The transaction is expected to close in January 2020. Shares of ph...
Streetwise Reports | December 13, 2019 |

Syndax Pharma Shares Rise on $35M Capital Raise, Credit Line and Positive Phase 1/2 Leukemia ...

Syndax Pharma Shares Rise on $35M Capital Raise, Credit Line and Positive Phase 1/2 Leukemia Trial Results Syndax Pharmaceuticals' shares traded 30% higher after the company reported it expects to raise $35 million from a common stock offering from five instituti...
Streetwise Reports | February 3, 2020 |

ImmunoGen Shares Rise 25% on FY/19 Financial Results and Clinical Pipeline Updates

Shares of ImmunoGen Inc. reached a new 52-week intraday high price after the company announced FY/19 financial results and reported on recent developments including the completion of a $97.6 million capital raise in January 2020. Clinical-stage biotechnology...
Streetwise Reports | February 18, 2020 |

Surface Oncology Shares Trade Up 40% on Phase1 Study Plans for SRF617 Combined with Merck's KEYTRUDA

Shares of Surface Oncology set a new 52-week high price after the company reported that it is partnering with Merck & Co. in an immuno-oncology study of SRF617, targeting CD39 in combination with KEYTRUDA® (pembrolizumab) in solid tumor patients. Clinical-...
Streetwise Reports | May 21, 2020 |
1 2 3 4 5 6 7 8 9 10 ...